Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis

Infection and Immunity

Volumn 67, Issue 3, 1999, Pages 1267-1276

  Rosenqvist, Einar ^a   Musacchio, Alexis ^a,d   Aase, Audun ^a   Høiby, E Arne ^a   Namork, Ellen ^a   Kolberg, Jan ^a   Wedege, Elisabeth ^a   Delvig, Alexei ^a   Dalseg, Rolf ^a   Michaelsen, Terje E ^a,b   Tommassen, Jan ^c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UTRECHT UNIVERSITY   (Netherlands)

^d CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIBODY STRUCTURE; ANTIGEN ANTIBODY REACTION; ARTICLE; EPITOPE MAPPING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NEISSERIA MENINGITIDIS; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN PURIFICATION;

EID: 0032976185     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.3.1267-1276.1999     Document Type: Article

References (62)

1. Aase, A., I. Sandlie, L. Norderhaug, O. H. Brekke, and T. E. Michaelsen. 1993. The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fca receptors, but the heavy chains must be disulfide bonded. Eur. J. Immunol. 23:1546-1551.
2. Achtman, M., B. Kusecek, G. Morelli, K. Eickmann, J. Wang, B. Crowe, R. A. Wall, M. Hassan-King, P. S. Moore, and W. D. Zollinger. 1992. A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J. Infect. Dis. 165:53-68.
3. Andersen, S. R., J. Kolberg, E. A. Høiby, E. Namork, D. A. Caugant, L. O. Frøholm, E. Jantzen, and G. Bjune. 1997. Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development. Microbiol. Pathol. 23:139-155.
4. Arhin, F. F., F. Moreau, J. W. Coulton, and E. L. Mills. 1997. Subtyping of Neisseria meningitidis strains isolated in Quebec, Canada: correlation between deduced amino acid sequences and serosubtyping techniques. Can. J. Microbiol. 43:234-238.
5. Arminjon, F., M. Cadoz, S. A. Morse, J. P. Rock, and S. K. Sarafian. 1987. Bactericidal and opsonic activities of sera from individuals immunized with a gonococcal protein 1 vaccine, abstr. E-92, p. 118. In Abstracts of the Annual Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
6. Bjune, G., E. A. Høiby, J. K. Grønnesby, O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A.-K. Lindbak, H. Nøkleby, E. Rosenqvist, L. K. Solberg, O. Closs, J. Eng, L. O. Frøholm, A. Lystad, L. Bakketeig, and B. Hareide. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
7. Blake, M. S., L. M. Wetzler, E. C. Gotschlich, and P. A. Rice. 1989. Protein III: structure, function, and genetics. Clin. Microbiol. Rev. 2(Suppl.):S60-S63.
8. Cowan, S. W., T. Schirmer, G. Rummel, M. Steiert, R. Ghosh, R. A. Paupit, J. N. Jansonius, and J. P. Rosenbusch. 1992. Crystal structure explains functional properties of two E. coli porins. Nature 358:727-733.
9. Danelli, M. G., N. M. Batoreu, M. D. Lacerda, C. R. B. Ferreira, J. Darc Cardoso, J. M. Peralta, and C. E. Frasch. 1995. Surface antigen analysis of group B Neisseria meningitidis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein. Curr. Microbiol. 31:146-151.
10. Dekker, N., K. Merck, J. Tommassen, and H. M. Verheij. 1995. In vitro folding of Escherichia coli outer membrane phospholipase A. Eur. J. Biochem. 232:214-219.
11. Delvig, A. A., E. Wedege, D. A. Caugant, R. Dalseg, J. Kolberg, M. Achtman, and E. Rosenqvist. 1995. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine. Microbiology 141: 1593-1600.
12. Finnen, R. L., N. L. Martin, R. J. Siehnel, W. A. Woodruff, M. Rosok, and R. E. W. Hancock. 1992. Analysis of the Pseudomonas aeruginosa major outer membrane protein OprF by use of truncated OprF derivatives and monoclonal antibodies. J. Bacteriol. 174:4977-4985.
13. Frasch, C. E., W. D. Zollinger, and J. T. Poolman. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:504-510.
14. Fredriksen, J. H., E. Rosenqvist, E. Wedege, K. Bryn, G. Bjune, L. O. Frøholm, A.-K. Lindbak, B. Møgster, E. Namork, U. Rye, G. Stabbetorp, R. Winsnes, B. Aase, and O. Closs. 1991. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14:67-79.
15. Geysen, H. M., S. J. Rodda, T. J. Mason, G. Tribbick, and P. G. Schoofs. 1987. Strategies for epitope analysis using peptide synthesis. J. Immunol. Methods 102:259-274.
16. Gilleland, L. B., and H. E. Gilleland, Jr. 1995. Synthetic peptides representing two protective, linear B-cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific. Infect. Immun. 63:2347-2351.
17. Gotschlich, E. C. 1991. The meningococcal serogroup B vaccine protection trials: concluding remarks at the report meeting second day. NIPH Ann. 14:247-250.
18. Gotschlich, E. C., M. Seiff, and M. S. Blake. 1987. The DNA sequence of the structural gene of gonococcal protein III and the flanking region containing a repetitive sequence. J. Exp. Med. 165:471-482.
19. Gulati, S., P. A. Rice, M. S. Blake, S. K. Sarafian, S. A. Morse, M. J. Quentin-Millet, and F. Arminjon. 1990. Antibody responses in six volunteers immunized with a gonococcal protein I vaccine, p. 229-234. In M. Achtman, P. Kohl, C. Marchal, G. Morelli, A. Seiler, and B. Thiesen (ed.), Neisseria 1990. Walter de Gruyter, Berlin, Germany.
20. Høiby, E. A., E. Rosenqvist, L. O. Frøholm, G. Bjune, B. Feiring, H. Nøkleby, and E. Rønnild. 1991. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. NIPH Ann. 14:147-156.
21. Hughes, E. E., and H. E. Gilleland, Jr. 1995. Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against Pseudomonas aeruginosa infection in murine acute pneumonia model. Vaccine 13:750-753.
22. Hughes, E. E., J. M. Matthews-Greer, and H. E. Gilleland, Jr. 1996. Analysis by flow cytometry of surface-exposed epitopes of outer membrane protein F of Pseudomonas aeruginosa. Can. J. Microbiol. 42:859-862.
23. Joiner, K., R. A. Scales, K. A. Warren, M. M. Frank, and P. A. Rice. 1985. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J. Clin. Invest. 76:1765-1772.
24. Kadurugamuwa, J. L., and T. J. Beveridge. 1995. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177:3998-4008.
25. Klugman, K. P., E. C. Gotschlich, and M. S. Blake. 1989. Sequence of the structural gene (rmpM) for the class 4 outer membrane protein of Neisseria meningitidis, homology of the protein to gonococcal protein III and Escherichia coli OmpA, and construction of meningococcal strains that lack class 4 protein. Infect. Immun. 57:2066-2071.
26. Koebnik, R. 1995. Proposal for a peptidoglycan-associating alpha-helical motif in the C-terminal regions of some bacterial cell-surface proteins. Mol. Microbiol. 16:1269-1270.
27. Kolberg, J., E. A. Høiby, R. Lopez, and K. Sletten. 1997. Monoclonal antibodies against Streptococcus pneumoniae detect epitopes on eubacterial ribosomal proteins L7/L12 and on streptococcal elongation factor Ts. Microbiology 143:55-61.
28. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydrophobic character of a protein. J. Mol. Biol. 157:105-132.
29. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of hacteriophage T4. Nature 227:680-685.
30. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
31. Lytton, E. J., and M. S. Blake. 1986. Isolation and partial characterization of the reduction-modifiable protein of Neisseria gonorrhoeae. J. Exp. Med. 164: 1749-1759.
32. McDade, R. L., and K. H. Johnston. 1980. Characterization of serologically dominant outer membrane proteins of Neisseria gonorrhoeae. J. Bacteriol. 141:1183-1191.
33. Moran, E. E., B. L. Brandt, and W. D. Zollinger. 1994. Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity. Infect. Immun. 62:5290-5295.
34. Munkley, A., C. R. Tinsley, M. Virji, and J. E. Heckels. 1991. Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein. Microb. Pathog. 11:447-452.
35. Newhall, W. J., W. D. Sawyer, and R. A. Haak. 1980. Cross-linking analysis of outer membrane proteins of Neisseria qonorrhoeae. Infect. Immun. 28: 785-790.
36. Paul, C., and J. P. Rosenbusch. 1985. Folding patterns of porins and bacteriorhodopsin. EMBO J. 4:1593-1597.
37. Plummer, F. A., H. Chubb, J. N. Simonsen, M. Bosire, L. Slaney, I. Maclean, J. O. Ndinya-Achola, P. Waiyaki, and R. C. Brunham. 1993. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection. J. Clin. Invest. 91:339-343.
38. Poolman, J. T., F. B. Wientjes, C. T. P. Hopman, and H. C. Zanen. 1985. Influence of the length of lipopolysaccharide molecules on the surface exposure of class 1 and 2 outer membrane proteins of Neisseria meningitidis 2996 (B:2b:P1.2), p. 562-570. In G. K. Schoolnik, G. F. Brooks, S. Falkow, C. E. Frasch, J. S. Knapp, J. A. McCutchan, and S. A. Morse (ed.), The pathogenic neisseriae. American Society for Microbiology. Washington, D.C.
39. Rawling, E. G., N. L. Martin, and R. E. W. Hancock. 1995. Epitope mapping of the Pseudomonas aeruginosa major outer membrane porin protein OprF. Infect. Immun. 63:38-42.
40. Rest, R. F., G. C. Chen, and E. C. Gotschlich. 1996. Neisseria gonorrhoeae mutants lacking outer membrane protein Rmp (PIII) are deficient in invasion of human epithelial cells, p. 267-269. In W. D. Zollinger, C. E. Frasch, and C. D. Deal (ed.), Tenth International Pathogenic Neisseria Conference, Baltimore, Md., September 1996.
41. Rice, P. A., H. E. Vayo, M. R. Tam, and M. S. Blake. 1986. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J. Exp. Med. 164:1735-1748.
42. Ried, G., R. Koebnik, I. Hindennach, B. Mutschler, and U. Henning. 1994. Membrane topology and assembly of the outer membrane protein OmpA of Escherichia coli K12. Mol. Gen. Genet. 243:127-135.
43. Rosenqvist, E., E. Wedege, E. A. Høiby, and L. O. Frøholm. 1990. Serogroup determination of Neisseria meningitidis by whole-cell ELISA, dot-blotting and agglutination. APMIS 98:501-506.
44. Rosenqvist, E., E. A. Høiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Rønnild, G. Bjune, and H. Nøkleby. 1995. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:4642-4652.
45. Schirmer, T., T. A. Keller, Y. F. Wang, and J. P. Rosenbusch. 1994. Structural basis for sugar translocation through maltoporin channels at 3.1 A resolution. Science 267:512-514.
46. Sugawara, E., and H. Nikaido. 1992. Pore-forming activity of OmpA protein from Escherichia coli. J. Biol. Chem. 267:2507-2511.
47. Sugawara, E., M. Steiert, S. Rouhani, and H. Nikaido. 1996. Secondary structure of the outer membrane proteins OmpA of Escherichia coli and OprF of Pseudomonas aeruginosa. J. Bacteriol. 178:6067-6069.
48. Swanson, J., L. W. Mayer, and M. R. Tam. 1982. Antigenicity of Neisseria gonorrhoeae outer membrane protein(s) III detected by immunoprecipitation and Western blot transfer with a monoclonal antibody. Infect. Immun. 38:668-672.
49. Tommassen, J. 1988. Biogenesis and membrane topology of outer membrane proteins in Escherichia coli, p. 352-373. In J. A. F. Op den Kamp (ed.), Membrane biogenesis. NATO ASI series. Springer-Verlag, Berlin, Germany.
50. Tsai, C. M., C. E. Frasch, and L. F. Mocca. 1981. Five structural classes of major outer membrane proteins in Neisseria meningitidis. J. Bacteriol. 146: 69-78.
51. van der Voort, E. R., P. van der Ley, J. Van der Biezen, S. George, O. Tunnela, H. van Dijken, B. Kuipers, and J. Poolman. 1996. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine. Infect. Immun. 64: 2745-2751.
52. Virji, M., K. Zak, and J. E. Heckels. 1987. Outer membrane protein III of Neisseria gonorrhoeae: variations in biological properties of antibodies directed against different epitopes. J. Gen. Microbiol. 133:3393-3401.
53. Virji, M., and J. E. Heckels. 1988. Non-bactericidal antibodies against Neisseria gonorrhoeae: evaluation of their blocking effect on bactericidal antibodies directed against outer membrane antigens. J. Gen. Microbiol. 134:2703-2711.
54. Virji, M., and J. E. Heckels. 1989. Location of a blocking epitope on outer-membrane protein III of Neisseria gonorrhoeae by synthetic peptide analysis. J. Gen. Microbiol. 135:1895-1899.
55. Wedege, E., and L. O. Frøholm. 1986. Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting. Infect. Immun. 51:571-578.
56. Wedege, E., and T. E. Michaelsen. 1987. Human immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine. J. Clin. Microbiol. 25:1349-1353.
57. Wedege, E. Unpublished data.
58. Weiss, M. S., U. Abele, J. Weckesser, W. Welte, E. Schiltz, and G. E. Schultz. 1991. Molecular architecture and electrostatic properties of a bacterial porin. Science 254:1627-1630.
59. Wolf, K., and A. Stern. 1995. Identification and characterization of specific sequences encoding pathogenicity associated proteins in the genome of commensal Neisseria species. FEMS Microbiol. Lett. 125:255-264.
60. Wong, R. S. Y., R. A. Wirtz, and R. E. W. Hancock. 1995. Pseudomonas aeruginosa outer membrane protein OprF as an expression vector for foreign epitopes: the effects of positioning and length on the antigenicity of the epitope. Gene 158:55-60.
61. Woodruff, W. A., and R. E. W. Hancock. 1989. Pseudomonas aeruginosa outer membrane protein F: structural role and relationship to the Escherichia coli OmpA protein. J. Bacteriol. 171:3304-3309.
62. Zollinger, W., R. A. Kuschener, B. Brandt, E. E. Moran, D. Shoemaker, M. Blake, and J. Mays. 1994. Phase 1 study of two meningococcal outer membrane protein vaccines prepared from a class 4 outer membrane protein negative mutant and its isogenic parent, p. 449. In J. S. Evans, S. E. Jost, M. C. J. Maiden, and I. M. Feavers (ed.), Proceedings of the Ninth International Pathogenic Neisseria Conference, Winchester, England, September 1994.